|
|
|
|
|
|
|
|
|
|
Bionomics launches ovarian cancer trial - clinical trials, cancer, Bionomics, Biotechnology - Australian Life Scientist
Bionomics (ASX:BNO) has launched a clinical trial of its BNC105 cancer treatment candidate in women with ovarian cancer.
The Phase I/II trial will involve up to 134 women across 18 sites in Australia, New Zealand and the US.
In
Australia, the trial be conducted by the Australian and New Zealand
Gynaecological Oncology Group in conjunction with the National Health
and Medical Research Council Clinical Trials Centre.
Patients will receive BNC105 in conjunction with standard chemotherapy drugs carboplatin and gemcitabine......
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.